• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS/RESPIRONICS INC. REM STAR PRO CPAP; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS/RESPIRONICS INC. REM STAR PRO CPAP; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Model Number 460P
Device Problem Use of Device Problem (1670)
Patient Problem Cancer (3262)
Event Date 04/05/2022
Event Type  Injury  
Event Description
Began using philips brand cpap in 2014.Diagnosed with stage 4 metastatic colon cancer on (b)(6) 2022.Cancer has spread to liver, lungs and spine.Reference report: mw5118398.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REM STAR PRO CPAP
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
PHILIPS/RESPIRONICS INC.
MDR Report Key17135521
MDR Text Key317335166
Report NumberMW5118397
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 06/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number460P
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/14/2023
Patient Sequence Number1
Treatment
GABAPENTIN, ATROPINE, DECADRON, ADRUCIL, ESOMEPRAZOLE MAGNESIUM, ONDANSETRON, AMOXICILLIN, OMEPRAZOLE, TROSPIUM CHLORIDE, LASIX, POTASSIUM CHLORIDE, TIZANIDINE, TRAMADOL, PEGRILGRASUM, FAMOTIDINE, CICLOPIROX OLAMINE, FLUOCINONIDE. ; ROBITUSSIN, ALEVE, CLARITIN, TYLENOL.
Patient Outcome(s) Hospitalization; Life Threatening; Other;
Patient Age76 YR
Patient SexMale
Patient Weight104 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-